Variables | EUS-FNA (n = 77) | EUS-FNB (n = 74) | P value |
---|---|---|---|
Adequate tissue reported by a pathologist, n (%) | 57 (74) | 74 (100) | < 0.001 |
Diagnostic yield, n (%) | Â | Â | Â |
 Overall | 69 (89.6) | 70 (94.6) | 0.406 |
 In mass size < 4 cm | 39/47 (83) | 40/43 (93) | 0.146 |
 In mass size > 4 cm | 30/30 (100) | 30/31 (96.8) | 1 |
Diagnosis following EUS-TA, n (%) | Â | Â | 0.232 |
 Pancreatic adenocarcinoma | 40 (51.9) | 52 (70.3) |  |
 Pancreatic neuroendocrine tumour | 8 (10.4) | 5 (6.8) |  |
 Mass forming chronic pancreatitis | 10 (13) | 3 (4.1) |  |
 Pancreatic lymphoma | 4 (5.2) | 3 (4.1) |  |
 Pancreatic tuberculosis | 2 (2.6) | 1 (1.4) |  |
 Other diseases | 5 (6.5) | 6 (8.1) |  |
 Non-diagnostic | 8 (10.4) | 4 (5.4) |  |
Severe adverse event, n (%) | 0 (0) | 1 (0.7) | 0.49 |
Stage of disease in patient with pancreatic cancer (AJCC), n (%) | N = 40 | N = 52 | 0.087 |
 I | 1 (2.5) | 1 (1.9) |  |
 II | 8 (20) | 3 (5.8) |  |
 III | 21 (52.5) | 26 (50) |  |
 IV | 10 (25) | 22 (42.3) |  |